Formulation and evaluation of gastro-retentive floating matrix tablets of Nevirapine

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn 4, Issue SUPPL. 5, 2012, Pages 368-375

  Sowjanya, K ^a   Shobha Deepthi, K ^a   Bharathi, A ^a  

^a KVSR SIDDHARTHA COLLEGE OF PHARMACEUTICAL SCIENCES   (India)

Author keywords

Ethocel; Floating matrix tablets; Gastro retentive; HPMC; Nevirapine

Indexed keywords

NEVIRAPINE; POLYMER;

ARTICLE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG FORMULATION; DRUG HALF LIFE; DRUG RELEASE; DRUG SCREENING; DRUG SOLUBILITY; DRUG SYNTHESIS; FLOATING MATRIX TABLET; INFRARED SPECTROSCOPY; TABLET;

EID: 84870751239     PISSN: None     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Iannuccelli V, Coppi G, Bernabei MT, Cameroni R, Air compartment multiple-unit system for prolonged gastric residence. Part I. Formulation study, Int. J. Pharm 1998; 174: 47-54.
2. Menon A, Ritschel WA, Sakr A, Development and e v a l u a t i o n of a monolithic floating dosage form for furosemide, J. Pharm. Sci, 1994; 83: 239-245.
3. Whitehead L, Fell JT, Collett JH, Sharma HL, Smith AM, Floating dosage forms: an in-vivo study demonstrating prolonged gastric retention, J. Control. Rel. 1998; 55: 3-12.
4. Santus G, Lazzarini G and Bottoni G. An in-vitro in-vivo investigation of oral bioadhesive controlled release furosemide formulations. Eur. J. Pharm. Biopharm, 1997; 4: 39-52.
5. Deshpande AA, Shah NH, Rhodes CT, Malick W, Development of a novel controlled-release system for gastric retention, Pharm. Res 1997; 14: 815-819.
6. Deshpande AA, Rhodes CT, Shah NH, Malick AW, Controlledrelease drug delivery systems for prolonged gastric residence: an overview, Drug. Dev. Ind. Pharm1996; 22: 531-539.
7. Groning R and Heun G, Dosage forms with controlled gastrointestinal passage-studies on the absorption of nitrofurantoin, Int. J. Pharm 1989; 56: 111-116.
8. Streubel A, Siepmann J and Bodmeier R, Floating matrix tablets based on low density foam powder: effects of formulation and processing parameters on drug release, Eur. J. Pharm. Sci 2003; 18: 37-45.
9. Baumgartner S, Krist J, Vrecer F, Vodopivec P, Zorko B, Optimization of floating matrix tablets and evaluation of their gastric residence time, Int J Pharma 2000;195: 125-135.
10. Moes AJ Gastro retentive dosage forms, Crit Rev Ther Drug Carrier Syst, 1993; 10:143-159.
11. Bacolla A, Shih CK, Rose JM, Effect on Kinetic Constants and Inhibition by Non-nucleoside Analogs, Journal of Biochemistry 1993; 268: 16571-16577.
12. D. Skowron, G. Leoung, DB. Hall, et al. Pharmacokinetic evaluation and short-term activity of stavudine, nevirapine, and nelfinavir therapy in HIV-1-infected adults. J Acquir Immune Defic Syndr 2004; 35: 351-358.
13. Nevirapine. AHFS Drug Info. 2004; 1-8.
14. Hawi A, Bell G. Preformulation studies of nevirapine, a reverse transcriptase inhibitor. Pharm Res 1994; 11: 236.
15. Sreeraj Macha, Chan-Loi Yong et al. Assessment of Nevirapine Bioavailability from targeted sites in the Human Gastro intestinal Tract. The journal of Clinical Pharmacology. J clin Pharmacol 2009; 49 (12): 1417-1425.
16. Prasad YR, Rajasekhar KK, Shankarananth V, Yaminikrishna HV, Saikumar S, Reddy PV, Spectrophotometric method for the estimation of Domperidone in bulk and pharmaceutical formulations, J. Pharm Res 2009; 2: 1593-4.
17. Uma Vasi Reddy, Lakshmi Narasimha Reddy, Poorna Chander T, Prashanth V. Formulation and evaluation of oral disintegrating tablets of salbutamol sulphate. Int. J. Pharm & Ind. Res., 1, 2011, 63-66.
18. Jinichi F, Etsuo Y, Yasuo Y, Katsuhide T, Evaluation of rapidly disintegrating tablets containing glycine and carboxymethylcellulose. Int J Pharm 2006; 101-119.
19. Rosa M, Zia H and Rhodes T, Dosing and testing in-vitro of a bioadhesive and floating drug delivery system for oral application. Int. J. Pharm. 1994; 105: 65-70.
20. Official Monograph, Nevirapine, USP 34, 3648-3649.
21. Nevirapine. AHFS Drug Info. 2004; 1-8
22. http//:en.wikipedia.org/wiki/Nevirapine (1998).
23. Cheeseman SH, Havlir D, McLaughlin MM, et al. Phase I/II evaluation of Nevirapine alone and in combination with zidovudine for infection with human immunodeficiency virus. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 8: 141-151.
24. Dushant D G, Vaishali L. Formulation and evaluation of extended release tablets of Nevirapine. Journal of Pharmacy Research, 2012; 5(1): 147-149.
25. http://www.fda.gov/cder/foi/label/2008/020636s027,02093 3s017lbl.pdf. Accessed 03/12/09.
26. http://www.factsandcomparisons.com. Accessed 03/12/09
27. http://www.drugbank.com/nevirapine/DB00238. Accessed 03/12/09
28. Hari BN Vedha, Reddy A Brahma et al. Floating drug delivery of nevirapine as Gastro retentive system. Journal of young Pharmacists. J Young Pharm. 2010; 2(40): 350-355.
29. Lokamatha K. M, Shanta Kumar S. M, Rama Rao N. Enhancement of Solubility and Dissolution Rate of Nevirapine by Solid Dispersion Technique Using Dextran: Preparation and In Vitro Evaluation. International Journal of Pharma. Research & Development, 2011; 2(12): 1-8.
30. Arpan C, Vineetkumar P et al.2011. A novel lipid based oral drug delivery system of Nevirapine. International journal of Pharmtech research. 2011; 3(2):1159-1168.
31. Bajaj H, Bisht S, Yadav M, Singh V and Singh M. Design and Development of Nevirapine Loaded Surfactant Free Chitosan Micro emulsion. Acta Poloniae Pharmaceutica-Drug Research 2011; 68(6): 981-988.
32. Rohini P, Madhusudhanareddy I et al. 2011. Method development and validation for estimation of Nevirapine from tablets by RPHPLC. International Journal of pharmacy 2011; 1(1): 29-33.
33. Venkata Reddiah C. H, Rama Devi P, Mukkanti K, et al. Estimation of Nevirapine by UV-VIS Spectroscopic Method in Extended Release (ER) Tablet Dosage Forms and it's In Vitro Dissolution Assessment. International Journal of Pharmaceutical Research and Development 2011; 4(2): 1-9.
34. Sarkar M, Perumal O.P. Solid state characterization of Nevirapine. Indian Journal of Pharmaceutical Sciences. Indian J Pharm Sci. 2008; 70(5): 619-630.
35. Anilkumar J, Arun N. Formulation and evaluation of floating matrix tablets of cephalexin using Hydrophilic polymers. International journal of pharmacy and pharmaceutical sciences. Int J Pharmacy Pharm sci. 2010; 2(2): 58-65
36. Sridhar N. Y, Rajasekhar E. Dissolution method development of Lamivudine, Nevirapine and stavudine in Tablets by UPLC. Int J pharmacy Pharm sci. 2012; 4 (3): 113-117.